A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)

BACKGROUND: Patient access to orphan medicinal products (OMPs) is limited and varies between countries, reimbursement decisions on OMPs are complex, and there is a need for more transparent processes to know which criteria should be considered to inform these decisions. This study aimed to determine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Orphanet J Rare Dis
Main Authors: de Andrés-Nogales, Fernando, Cruz, Encarnación, Calleja, Miguel Ángel, Delgado, Olga, Gorgas, Maria Queralt, Espín, Jaime, Mestre-Ferrándiz, Jorge, Palau, Francesc, Ancochea, Alba, Arce, Rosabel, Domínguez-Hernández, Raquel, Casado, Miguel Ángel
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8073956/
https://ncbi.nlm.nih.gov/pubmed/33902672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-021-01809-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados